Camcevi

Active Ingredient(s): Leuprolide Mesylate
FDA Approved: * May 25, 2021
Pharm Company: * FORESEE PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Camcevi Overview

Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty, or as part of transgender hormone therapy.[6][7] It is given by injection into a muscle or under the skin.[6] Common side effects include hot flashes, unstable mood, trouble sleeping, headaches, and pain at the site of injection.[6] Other side effects may i...

Read more Camcevi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Leuprorelin

Recent Camcevi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Leuprolide Mesylate
  • Emulsion: 42mg
  • For Suspension: 22.5mg/vial
  • Implant: 65mg
  • Injection: 11.25mg, 15mg, 1mg/0.2ml, 22.5mg, 22.5mg/vial, 3.75mg, 30mg, 30mg/vial, 45mg, 45mg/vial, 5mg/ml, 7.5mg, 7.5mg/vial
  • Powder: 7.5mg
  • Suspension: 11.25mg, 22.5mg, 3.75mg, 7.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Leuprolide Mesylate or a similar ingredient: (5 results)